Related Experiment Video
Updated: Jun 8, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
AIDS-associated cancers: an emerging challenge.
Uday A Phatak1, Ravindra Joshi, Dinesh K Badakh
1Department of General Medicine, Shri Siddhi Vinayak Ganapati Cancer Hospital, Miraj.
Concurrent chemotherapy and anti-retroviral therapy show effectiveness in treating AIDS-associated cancers in Indian patients. These combined treatments improve outcomes for individuals with advanced HIV infection and related malignancies.
Area of Science:
- Oncology
- Infectious Diseases
- Public Health
Background:
- Acquired Immunodeficiency Syndrome (AIDS)-associated cancers represent a significant challenge in HIV-infected individuals.
- Understanding the interplay between cancer chemotherapy and anti-retroviral therapy (ART) is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the incidence and impact of combined cancer chemotherapy and ART on the outcomes of AIDS-associated cancers in Indian patients.
- To evaluate the effectiveness of concurrent treatment modalities in managing HIV-related malignancies.
Main Methods:
- A 5-year prospective study involving 3832 cancer patients, identifying 46 with AIDS-associated cancers.
- HIV status confirmed via ELISA, Western Blot, viral load, and CD4/CD8 counts.
- Patients received various cancer treatments alongside ART, with 6-monthly follow-ups.
Main Results:
- The incidence of AIDS-associated cancers was 1.2%, with AIDS-Defining Cancers (ADC) in 54.35% and non-AIDS-Defining Cancers (NADC) in 45.65%.
- Non-Hodgkin Lymphoma was the most common ADC (84%), followed by cervical cancers (16%); Kaposi's Sarcoma was absent.
- Only 33.5% of patients received combined HIV and cancer treatment, with immune reconstitution syndrome observed in 9.09%.
Conclusions:
- AIDS-associated cancers typically occur in advanced HIV infection stages.
- Concurrent chemotherapy and ART demonstrate significant efficacy in treating AIDS-associated malignancies.
- Cervical cancers and NADCs showed less predictable responses to ART, and mortality was higher in non-AIDS-related cancers.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Treatment Resistent Cancers
Treatment Resistant Cancers
Amebiasis
Sexually Transmitted Infections

